Entrada Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Bostonmassachusettsthe Company Is Dedicated To Developing Innovative Therapeutics Using Its Endosomal Escape Vehicleeeva Cplatformthis Technology Aims To Deliver Biologics Efficiently Into Cellstargeting Intracellular Pathways That Are Often Consideredundruggable Entrada S Mission Is To Transform Patient Lives By Addressing Severe Diseases Through Improved Drug Deliverythe Eeva C Platform Is Designed To Enhance The Bioavailability Of Various Therapeuticsincluding Oligonucleotidesantibodiesand Enzymeswhile Minimizing Off Target Effectsthe Company Is Actively Working On Therapies For Neuromuscular Diseasesincluding Treatments For Duchenne Muscular Dystrophy And Myotonic Dystrophy Type 1Among Other Therapeutic Areas Such As Immunology And Oncologyas A Publicly Traded Company On Nasdaqentrada Therapeutics Employs Between 201 And 500 Professionals And Is Positioned To Lead In The Biologics Space With Its Innovative Approach To Intracellular Delivery
